| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Nov 13, 2025 | Organon & Co. | Chair | Buy | 97.5 | +65,400 | 524.50% | ✗ | $501.8K |
| May 14, 2025 | May 15, 2025 | Organon & Co. | Director | Buy | 95.0 | +12,469 | 100.00% | ✗ | $100.6K |
| Jul 31, 2023 | Aug 3, 2023 | TEXAS INSTRUMENTS INC | Director | Sell | 17.5 | -16,055 | -30.96% | ✗ | $2.9M |
| Jun 13, 2022 | Jun 15, 2022 | Cartesian Therapeutics, Inc. | Director | Buy | 95.0 | +130,000 | 156.85% | ✗ | $149.8K |
| Dec 3, 2021 | Dec 6, 2021 | Cartesian Therapeutics, Inc. | Director | Buy | 95.0 | +17,200 | 26.19% | ✗ | $50.7K |
| Oct 23, 2020 | Oct 27, 2020 | TEXAS INSTRUMENTS INC | Director | Sell | 17.5 | -22,838 | -40.13% | ✗ | $3.4M |
| Jul 24, 2020 | Jul 27, 2020 | TEXAS INSTRUMENTS INC | Director | Sell | 17.5 | -26,905 | -44.13% | ✗ | $3.5M |
| Jun 6, 2019 | Jun 6, 2019 | electroCore, Inc. | Director | Buy | 91.3 | +10,000 | 90.91% | ✗ | $18.2K |
| Apr 29, 2019 | May 1, 2019 | TEXAS INSTRUMENTS INC | Director | Sell | 17.5 | -17,002 | -33.80% | ✗ | $2M |
| Dec 3, 2018 | Dec 4, 2018 | electroCore, Inc. | Director | Buy | 91.3 | +7,300 | 197.30% | ✗ | $49.6K |
| Aug 17, 2018 | Aug 20, 2018 | electroCore, Inc. | Director | Buy | 95.0 | +3,700 | 27.75% | ✗ | $50.9K |
| Jul 27, 2017 | Jul 31, 2017 | TEXAS INSTRUMENTS INC | Director | Sell | 17.5 | -14,000 | -30.81% | ✗ | $1.2M |